VaramirStart free · no cardSign in
COGT as of Oct 31 · 16:53 ET
COGTNasdaqPharmaceutical Preparations

Cogent Biosciences, Inc. · Brief

Next report

2 days

Nov 2 · before openest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
0 of 8≥ implied
avg implied
±17.8%
avg realized
±5.3%
Feb 25 '25±13.1%▼−6.30%×0.48
May 6 '25±45.6%▼−15.62%×0.34
Jul 10 '25±10.8%▲+4.33%×0.40
Aug 5 '25±9.4%▼−5.73%×0.61
Q3 FY25±37.0%▼−4.91%×0.13
Feb 17 '26±7.5%▲+2.98%×0.39
Q1 FY26±9.5%▲+0.68%×0.07
Q2 FY26±9.6%▼−2.03%×0.21
quarterimplied−50%0+50%realized×
Q2 FY26±9.6%▼−2.03%×0.21
Q1 FY26±9.5%▲+0.68%×0.07
Feb '26±7.5%▲+2.98%×0.39
Q3 FY25±37.0%▼−4.91%×0.13
Aug '25±9.4%▼−5.73%×0.61
Jul '25±10.8%▲+4.33%×0.40
2 older reports
May '25±45.6%▼−15.62%×0.34
Feb '25±13.1%▼−6.30%×0.48
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 2 report · est.

Bull2

325managers reporting a position in the latest quarterly filings13F · Jun 30 '26
+5.32%change in shares held by the ten largest reporting managers this quarter13F · Jun 30 '26

Bear2 of 4

5tracked funds holding COGTN-PORT · Aug 31 '26
1.14%of State Street SPDR S&P Biotech ETF's assets, the largest tracked-fund weightN-PORT · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

COGT report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 19impliedImplied move: ±14.1% into Nov 2 earnings (Oct 19 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.